Meridian Bioscience: Fiscal Q3 Earnings Snapshot

August 5, 2022 GMT

CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Friday reported a loss of $7.3 million in its fiscal third quarter.

On a per-share basis, the Cincinnati-based company said it had a loss of 16 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 17 cents per share.

The diagnostic test maker posted revenue of $67.8 million in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VIVO at